Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1).
about
Novel crosstalk to BMP signalling: cGMP-dependent kinase I modulates BMP receptor and Smad activityCrystal Structure of the cGMP-dependent Protein Kinase II Leucine Zipper and Rab11b Protein Complex Reveals Molecular Details of G-kinase-specific InteractionsEndogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cellsThe NO-cGMP-PKG signal transduction pathway is involved in the analgesic effect of early hyperbaric oxygen treatment of neuropathic pain.Regulation of the cGMP-cPKG pathway and large-conductance Ca2+-activated K+ channels in uterine arteries during the ovine ovarian cycleA bioinformatic and computational study of myosin phosphatase subunit diversity.PKG-1α leucine zipper domain defect increases pulmonary vascular tone: implications in hypoxic pulmonary hypertension.A novel gain-of-function mutant of the cyclic GMP-dependent protein kinase egl-4 affects multiple physiological processes in Caenorhabditis elegans.cGMP-dependent protein kinase I gamma encodes a nuclear localization signal that regulates nuclear compartmentation and function.Nitrergic neuromuscular transmission in the mouse internal anal sphincter is accomplished by multiple pathways and postjunctional effector cells.PKG II inhibits EGF/EGFR-induced migration of gastric cancer cellsGenetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Stabilization of cGMP-dependent protein kinase G (PKG) expression in vascular smooth muscle cells: contribution of 3'UTR of its mRNANitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinaseSynthetic Peptides as cGMP-Independent Activators of cGMP-Dependent Protein Kinase IαEndogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239.Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase IαTranscriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significanceHigh blood pressure arising from a defect in vascular function.The switch helix: a putative combinatorial relay for interprotomer communication in cGMP-dependent protein kinase.Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer.Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.cGMP-dependent protein kinases as potential targets for colon cancer prevention and treatment.Feeding-Related Traits Are Affected by Dosage of the foraging Gene in Drosophila melanogaster.Induction of apoptosis by type Iβ protein kinase G in the human breast cancer cell lines MCF-7 and MDA-MB-468.Alleviating brain stress: what alternative animal models have revealed about therapeutic targets for hypoxia and anoxiaFibronectin upregulates cGMP-dependent protein kinase type Iβ through C/EBP transcription factor activation in contractile cells.Cyclic AMP and cyclic GMP activate protein kinase G in cavernosal smooth muscle cells: old age is a negative factor.Functional analysis of type 1alpha cGMP-dependent protein kinase using green fluorescent fusion proteins.Cyclic AMP- and cyclic GMP-dependent protein kinases differ in their regulation of cyclic AMP response element-dependent gene transcription.Cyclic GMP specifically suppresses Type-Ialpha cGMP-dependent protein kinase expression by ubiquitination.Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo.Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic target.Multigene family encoding 3',5'-cyclic-GMP-dependent protein kinases in Paramecium tetraurelia cells.Protein kinase G regulates potassium chloride cotransporter-4 [corrected] expression in primary cultures of rat vascular smooth muscle cells.Nitric oxide signaling pathway regulates potassium chloride cotransporter-1 mRNA expression in vascular smooth muscle cells.Defective smooth muscle regulation in cGMP kinase I-deficient mice.Aromatic L-amino acid decarboxylase phosphorylation and activation by PKGIalpha in vitro.Activation of cGMP-dependent protein kinase by protein kinase C.Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes.
P2860
Q24323077-449B8915-546A-4DF0-B886-947A4E2C2184Q27684845-EB63BBA8-AACB-41BF-82E1-3FABEC65D719Q28564609-C3C18E3C-B01C-46CB-B0F9-4652262E5847Q33633558-0A2DF4B9-3003-4B27-9217-8C3BE62D3A3AQ33655515-CFE27D26-2807-41D8-9BD7-B396A814547AQ34001586-0A784EF9-2D98-4A49-8470-FC2386417D15Q34295259-B8B96178-F6A9-4D64-A8FC-8E76D56D9274Q34611353-BC5E3CAE-3EEB-4079-B26D-A8108C61A3F7Q34624062-9326C4F7-9A57-4BF5-A27C-DA516A3635D2Q34627499-9AB399BE-A4A6-40BE-8AFB-7032B1BF8B2DQ34684803-E461D0B3-7895-46AA-B670-A39776764904Q35008001-9116B4F1-4388-4256-BE43-07E9A471B65EQ35020902-E32C4D1E-F019-4416-B240-2D767C65797DQ35803799-939926A1-B8DC-4D25-9F26-0FC856A43880Q35873815-1499E116-6ED2-4227-9863-4130E66F55E4Q36403245-D01FAA21-624A-4468-BA7F-F069E9B56FD0Q36436116-FDC99AF9-F93C-4F96-8A5D-3916A075F97CQ36529020-C39638E7-3E4A-44BB-8A34-ECE546AE3784Q36638652-8405C33E-E17B-4C06-8F0C-57116376577FQ36931167-399068D0-CC3F-4F62-804E-6F7614627223Q37082792-98A67B5E-A0F7-40EE-A6BD-5D5A014CEC40Q37327723-8C03D870-060C-4987-B2B5-6C1D8CCCDD08Q37855854-C800DE61-A80B-4457-BF12-827AB4D56A63Q38779052-13BEDF83-C612-4850-A657-9815E71FE990Q39440899-A3F123E4-057F-447C-9836-1D4B28BF9ABAQ39495779-94FF29AD-951C-457C-949F-6BE240282B75Q39805358-75DEE755-9710-4652-837A-C46071FCF155Q40739339-BE3E9AB9-7EA9-430E-80F6-9BD26BF8E396Q40817121-4B1595EF-1EB3-4B07-85EB-642785CEBF50Q40966237-C040ABBB-9611-48CD-ADA1-76EB61E99DC5Q41885720-DF9C85A5-6FE5-4933-B510-5013B7F9BB76Q42133076-3CFCA46F-1061-436C-8AD6-D35E91847C20Q42162203-19627B12-50CE-4B39-A1F8-BBDF1428EB69Q42489017-535E7C4B-9B14-4E82-AEC0-D0AA1F589FDAQ42501830-5C96D730-CF5E-4CAA-8B8A-8461608289CCQ42510027-66A5894E-3AA8-4707-AED1-C1D4C62C32BEQ42645524-FA491DA7-857F-40B4-BF5C-B881749AE060Q43067878-E2886223-5C3A-44BF-A9F2-CE5CE5E914D4Q44333340-13AD4B2A-4765-4A09-B24D-07E9317BD1E1Q44582563-DAFAAE98-C1F2-4CE3-B389-8B14C6B45B72
P2860
Characterization of the human gene encoding the type I alpha and type I beta cGMP-dependent protein kinase (PRKG1).
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Characterization of the human ...... endent protein kinase (PRKG1).
@ast
Characterization of the human ...... endent protein kinase (PRKG1).
@en
Characterization of the human ...... cGMP-dependent protein kinase
@nl
type
label
Characterization of the human ...... endent protein kinase (PRKG1).
@ast
Characterization of the human ...... endent protein kinase (PRKG1).
@en
Characterization of the human ...... cGMP-dependent protein kinase
@nl
prefLabel
Characterization of the human ...... endent protein kinase (PRKG1).
@ast
Characterization of the human ...... endent protein kinase (PRKG1).
@en
Characterization of the human ...... cGMP-dependent protein kinase
@nl
P2093
P356
P1433
P1476
Characterization of the human ...... endent protein kinase (PRKG1).
@en
P2093
Natarajan V
Orstavik S
P304
P356
10.1006/GENO.1997.4743
P577
1997-06-01T00:00:00Z